Global drugmakers could face new U.S. scrutiny after a report from lawmakers in India alleged abuses in that country’s drug approval process, lawyers familiar with such investigations said.
Popular Posts:
- FDA focuses on tracking drugs after approval
- Intercell launches Jeev vaccine in India
- FDA advisers consider time limit for bone drugs
- FDA advisers consider time limit for bone drugs
- Health law could affect fertility treatment coverage
Incoming search terms:
- case 4:09-cv-02556 united states district court southern district of texas houston division
- north cypress medical center operating co ltd et al v cigna healthcare et al case 4:09-cv-02556 docket update
- north cypress southern district houston and corporate representative
- ppaca prompt payment pharmacy